Literature DB >> 9705421

Dynamics of antigenemia and coproantigens during a human Fasciola hepatica outbreak.

A M Espino1, A Díaz, A Pérez, C M Finlay.   

Abstract

In the present study the dynamics of antigenemia and coproantigens were studied in patients with Fasciola hepatica infection during an outbreak occurring in La Palma, Pinar del Río, in the West Province of Cuba. Stool and serum samples were collected from 67 patients and 40 healthy subjects. Stool samples were studied by a simple gravity sedimentation technique and an ES78 sandwich enzyme-linked immunosorbent assay (ELISA) for observation of eggs and detection of parasite coproantigens, respectively. Serum samples were also studied by the ES78 sandwich ELISA and an indirect ELISA to detect circulating antigens and antibodies, respectively. At the beginning of the study, 8 of 67 patients had patent infections and 59 had prepatent infections, which was determined by the recent consumption of lettuce contaminated with metacercariae of F. hepatica, the presence of clinical symptoms, and the absence of Fasciola eggs in their stools. Patients with prepatent infections were monitored by all techniques until patency. Circulating antigens were not detected in patients with patent infections. However, coproantigens were clearly detected in all patients with patent infections. On the other hand, 28.8% of patients with prepatent infections tested positive for circulating antigens and 81.4% tested positive for coproantigens in the first stool sample studied. Only two other coproantigen determinations were necessary to diagnose 93.2% of the patients. While circulating antigen levels diminished in all patients during the infection, coproantigen levels increased. The present study demonstrates that the ES78 sandwich ELISA is a better tool than parasitological examination for diagnosis of active early infection, since by the combination of the circulating-antigen detection assay and the coproantigen detection assay 91% of patients were able to be diagnosed at the beginning of the study. In contrast, a coprologic analysis repeated over several weeks was necessary to diagnose 100% of the patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9705421      PMCID: PMC105191     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Detection of antibodies and circulating excretory-secretory antigens for assessing cure in patients with fascioliasis.

Authors:  A M Espino; J C Millán; C M Finlay
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

2.  Detection of Fasciola hepatica antigen in cattle faeces by a monoclonal antibody-based sandwich immunoassay.

Authors:  B E Duménigo; A M Espino; C M Finlay
Journal:  Res Vet Sci       Date:  1996-05       Impact factor: 2.534

3.  Fasciola hepatica: detection of antigenemia and coproantigens in experimentally infected rats.

Authors:  A M Espino; R Marcet; C M Finlay
Journal:  Exp Parasitol       Date:  1997-02       Impact factor: 2.011

4.  On human fascioliasis in Egypt.

Authors:  M Ragab; H F Farag
Journal:  J Egypt Med Assoc       Date:  1978

5.  Liver fluke in Great Britain: a survey of affected livers.

Authors:  G Froyd
Journal:  Vet Rec       Date:  1975 Dec 20-27       Impact factor: 2.695

6.  Detection of circulating excretory secretory antigens in human fascioliasis by sandwich enzyme-linked immunosorbent assay.

Authors:  A M Espino; R Marcet; C M Finlay
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

7.  Immunodiagnosis of human fascioliasis by enzyme-linked immunosorbent assay using excretory-secretory products.

Authors:  A M Espino; B E Duménigo; R Fernández; C M Finlay
Journal:  Am J Trop Med Hyg       Date:  1987-11       Impact factor: 2.345

8.  Comparison of counterelectrophoresis the enzyme-linked immunosorbent assay, and Kato fecal examination for the diagnosis of fascioliasis in infected mice and rabbits.

Authors:  D M Levine; G V Hillyer; S I Flores
Journal:  Am J Trop Med Hyg       Date:  1980-07       Impact factor: 2.345

9.  Fascioliasis--a large outbreak.

Authors:  E W Hardman; R L Jones; A H Davies
Journal:  Br Med J       Date:  1970-08-29

10.  Sandwich enzyme-linked immunosorbent assay for detection of excretory secretory antigens in humans with fascioliasis.

Authors:  A M Espino; C M Finlay
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more
  25 in total

1.  Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis.

Authors:  Kimberly Cabán-Hernández; José F Gaudier; Caleb Ruiz-Jiménez; Ana M Espino
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

2.  Evaluation of a 14.5 kDa-Fasciola gigantica fatty acid binding protein as a diagnostic antigen for human fascioliasis.

Authors:  Gamal Allam; Ibrahim R Bauomy; Zeinab M Hemyeda; Thabet F Sakran
Journal:  Parasitol Res       Date:  2011-11-24       Impact factor: 2.289

3.  Molecular cloning, expression, and characterization of cyclophilin A from Clonorchis sinensis.

Authors:  Weihua Wu; Jiajia Chen; Suxiang Zeng; Zhaoping Zhang; Wenjia Gan; Xinbing Yu; Xuchu Hu
Journal:  Parasitol Res       Date:  2011-03-01       Impact factor: 2.289

4.  Immunodiagnosis of human fascioliasis by an enzyme-linked immunosorbent assay (ELISA) and a micro-ELISA.

Authors:  S Carnevale; M I Rodríguez; G Santillán; J H Labbé; M G Cabrera; E J Bellegarde; J N Velásquez; J E Trgovcic; E A Guarnera
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

5.  Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis.

Authors:  Olgary Figueroa-Santiago; Bonnibel Delgado; Ana M Espino
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803

6.  Enzyme-linked immunosorbent assays for the detection of equine antibodies specific to a recombinant Fasciola hepatica surface antigen in an endemic area.

Authors:  María Sol Arias; Pablo Piñeiro; George V Hillyer; Iván Francisco; Cristiana Filipa Cazapal-Monteiro; José Luis Suárez; Patrocinio Morrondo; Rita Sánchez-Andrade; Adolfo Paz-Silva
Journal:  Parasitol Res       Date:  2011-08-17       Impact factor: 2.289

7.  Prevalence of natural ovine fasciolosis shown by demonstrating the presence of serum circulating antigens.

Authors:  A Paz-Silva; R Sánchez-Andrade; J L Suárez; J Pedreira; M Arias; C López; R Panadero; P Díaz; P Díez-Baños; P Morrondo
Journal:  Parasitol Res       Date:  2003-09-09       Impact factor: 2.289

8.  Differential expression and localization of saposin-like protein 2 of Fasciola hepatica.

Authors:  Kimberly Cabán-Hernández; Ana M Espino
Journal:  Acta Trop       Date:  2013-08-26       Impact factor: 3.112

9.  Fasciola hepatica ESPs Could Indistinctly Activate or Block Multiple Toll-Like Receptors in a Human Monocyte Cell Line.

Authors:  Olgary Figueroa-Santiago; Ana M Espino
Journal:  Ann Clin Pathol       Date:  2017-03-31

Review 10.  Recent Developments in Recombinant Proteins for Diagnosis of Human Fascioliasis.

Authors:  Abolfazl Mirzadeh; Farid Jafarihaghighi; Elham Kazemirad; Shokouh Shahrokhi Sabzevar; Mohammad Hossein Tanipour; Mehdi Ardjmand
Journal:  Acta Parasitol       Date:  2020-09-24       Impact factor: 1.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.